The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

The researchers then investigated how the metabolisms of treated mice changed. They found that the effect was caused by ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), is the most common form of chronic liver disease worldwide. This study aimed to ...

A doctor has warned people against making one common mistake when storing and eating leftover rice and pasta - as it could be ...

According to a 2018 article, at least 25 percent of adults have metabolic dysfunction–associated steatotic liver disease (MASLD), previously known as nonalcoholic fatty liver disease.

“If you have just been told you have MASLD, take a breath,” advised Tambini. “You are not alone, and you are not powerless.